2009-11-10 01:56:02 -

VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 11/09/09 -- Tekmira Pharmaceuticals Corporation (TSX: TKM), a leading developer of RNA interference (RNAi) therapeutics and proprietary delivery technology, announced today that it will hold a conference call and webcast on Thursday November 12, 2009 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to discuss third quarter 2009 operating results and to provide a corporate update.



About the Conference Call


To participate in the conference call, please dial 416-695-6617 or 1-800-355-4959. The call will be available for replay until November 26, 2009 by calling 416-695-5800 or 1-800-408-3053 and entering the code 2875305.



The live or archived webcast can also be accessed through the Company's website at www.tekmirapharm.com : .



About Tekmira


Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at www.tekmirapharm.com : . Tekmira is based in Vancouver, B.C.

Contacts:
The Equicom Group - Investors
Adam Peeler
416-815-0700 x 225
apeeler@equicomgroup.com :

Tekmira Pharmaceuticals Corporation
Ian Mortimer
Executive Vice President and Chief Financial Officer
604-419-3200
www.tekmirapharm.com :

Longview Communications Inc. - Media
David Ryan
604-694-6031
dryan@longviewcomms.ca :